46.46.Z - Wholesale trade of pharmaceutical and medical products
10.86.Z - Production of homogenized food products and diet food
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.1 - Wholesale trade conducted on behalf of others
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
73.1 - Advertising
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 9,6 | 13,6 | 13,6 | 0,7 |
EBITDA | 9,9 | 13 | 13,6 | 5 |
Short time liabilities | 34,9 | 53 | 58,8 | 10,9 |
Equity capital | 33 | 43,8 | 51,7 | 17,9 |
Operating profit (EBIT) | 9,7 | 12,8 | 13,4 | 4,4 |
Assets | 71,4 | 100,8 | 114,7 | 13,9 |
Net profit (loss) | 7,6 | 10,8 | 10,9 | 0,7 |
Cash | 2,5 | 1 | 2,9 | 200,4 |
Net income from sale | 155,9 | 192,3 | 217,7 | 13,2 |
Liabilities and provisions for liabilities | 38,4 | 56,9 | 63 | 10,7 |
Working assets | 70,2 | 98,9 | 112,8 | 14,1 |
Depreciation | 0,2 | 0,2 | 0,2 | 57,3 |
% | % | % | p.p. | |
Profitability of capital | 23,1 | 24,6 | 21 | -3,6 |
Equity capital to total assets | 46,3 | 43,5 | 45,1 | 1,6 |
Gross profit margin | 6,2 | 7,1 | 6,3 | -0,8 |
EBITDA Margin | 6,4 | 6,8 | 6,3 | -0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 101 | 99 | -2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane